Rare diseases
Investigational molecules
Locations
A study of YL201 and atezolizumab for patients with advanced solid tumors
ItalyStudy to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema
ItalyItalyA study of emavusertib and zanubrutinib in patients with chronic lymphocytic leukemia and other B-cell cancers.
ItalyA study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.
ItalyA study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease
ItalyA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
ItalyA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
ItalyA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
ItalyA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
ItalyA study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer
ItalyA Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
